Skip to content

Strength and Balance in Gender- and Age-Matched Controls

Strength and Balance in Gender- and Age-Matched Controls: SubStudy to The Effects of Vitamin D on Balance in Parkinson's Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02110875
Acronym
VITDC
Enrollment
25
Registered
2014-04-10
Start date
2013-06-30
Completion date
2014-02-28
Last updated
2014-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Keywords

Healthy Volunteers

Brief summary

The purpose of this study is to learn more about balance and strength in an elderly population (60 and older). Data will be compared between controls and the age/gender- matched PD participants in study The Effects of vitamin D on Balance in Parkinson's disease (OHSU IRB # 6482). Specifically a t-test will be used to compare total work and total power on leg extension and flexion, composite SOT score conditions 1-3 and 4-6, response strength and latency on MCT, and turn duration from the iMOBILITY between the two groups.

Detailed description

Inclusion Criteria: * Over the age of 59 * Gender and Age-Matched (within 3 years) of main protocol participants Exclusion Criteria: * Parkinson's disease diagnosis * Significant cognitive deficits. * Another neurological or orthopedic deficit that in the investigator's opinion would have a significant impact on gait and cognition (e.g. stroke, fracture). This study involves one visit to Oregon Health & Science University. The study visit will last approximately 2 hours. Measurements: 1. The participant's balance will be assessed by having them stand on a platform and completing mental tasks such as naming the alphabet backwards. They will be asked to have their eyes open on some tasks and closed on other tasks. For safety, they will wear a harness like those used by rock climbers. 2. The participant's ability to move and balance will be measured by putting six sensors on their bodies (both wrists, both ankles, chest, and back). Each sensor is about the size and weight of a deck of cards. To measure movement and balance, participants will rise from a chair, walk three feet, turn around, walk back to the chair, and sit down. 3. The participant's strength will be evaluated using a machine that resembles a stationary exercise bike. They will have one leg and foot strapped onto the machine. Participants will then be asked to flex and extend their leg as quickly as possible five times. This will be repeated with the other leg.

Interventions

None listed

Sponsors

Oregon Health and Science University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Over the age of 59 * Gender and Age-Matched (within 3 years) of main protocol participants

Exclusion criteria

* Parkinson's disease diagnosis * Significant cognitive deficits. * Another neurological or orthopedic deficit that in the investigator's opinion would have a significant impact on gait and cognition (e.g. stroke, fracture).

Design outcomes

Primary

MeasureTime frameDescription
Strength (BIODEX)Visit 1The participant's strength will be evaluated using a machine that resembles a stationary exercise bike. They will have one leg and foot strapped onto the machine. Participants will then be asked to flex and extend their leg as quickly as possible five times. This will be repeated with the other leg.

Secondary

MeasureTime frameDescription
Balance (SOT)Visit 1The participant's balance will be assessed by having them stand on a platform and completing mental tasks such as naming the alphabet backwards. They will be asked to have their eyes open on some tasks and closed on other tasks. For safety, they will wear a harness like those used by rock climbers.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026